Global Controlled Trial on Effects of an Online Self-Help Program for of Ambitious Altruists on Their Mental Health, Wellbeing, and Productivity: Comparing Versions With IFS vs. CBT, Buddy- vs. Group-, Standard- vs. Minimum-Guidance Intensity.
Launched by RETHINK WELLBEING · May 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different versions of a 16-week online self-help program designed to improve mental health, well-being, and productivity in individuals who are actively engaged in helping others, known as "ambitious altruists." The trial will compare how effective these programs are based on their format—whether participants receive guidance from a buddy or in a group, and whether the guidance is more intensive or minimal. Participants will take surveys at the beginning and during the program to share how they're feeling and how productive they are, helping researchers understand which version of the program works best.
To be eligible for this trial, participants should be between 65 and 74 years old and identify as ambitious altruists, meaning they are involved in activities that aim to help others. However, individuals who feel very socially isolated, those in a crisis, or those who do not consider themselves committed to altruistic causes cannot participate. If you join, you can expect to engage with the program online, track your progress through surveys, and contribute to important research that could help improve mental health support for people dedicated to making a positive impact.
Gender
ALL
Eligibility criteria
- Exclusion Criteria:
- • average of self-assessed sociality negative
- • people in acute crisis (they confirm and sign to not be in such a state)
- • people who self-report not to be ambitiously altruistic, i.g., not involved in the effective altruism community, or working on or planning to work on something impactful that might help others.
About Rethink Wellbeing
Rethink Wellbeing is a forward-thinking clinical trial sponsor dedicated to advancing mental health and wellness through innovative research and evidence-based interventions. Committed to enhancing the quality of life for individuals, Rethink Wellbeing focuses on developing and evaluating novel therapeutic approaches that address a wide range of psychological and emotional challenges. By fostering collaboration with healthcare professionals, researchers, and communities, the organization aims to drive transformative change in the mental health landscape, ultimately contributing to improved outcomes and greater accessibility to care for those in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wapenveld, , Netherlands
Patients applied
Trial Officials
Inga Grossmann, PhD.
Study Director
Rethink Wellbeing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported